Dan Deaton

Dan Deaton possesses extensive experience in product development and leadership within the pharmaceutical and healthcare sectors. Current roles include Interim Head of Inhaled Product Development and Executive Director of Patient Experience and Innovation at AstraZeneca, as well as Senior Director of Device Development. Additionally, Dan serves as an Angel Investor at Triangle Angel Partners, a Board Member at Community Workforce Solutions, and a Board Director at Polarean, Inc. Dan also holds the position of Managing Director at Grayscope Development. Dan's educational background includes a Master's degree in Mechanical Engineering from North Carolina State University and business training from the UNC Kenan-Flagler Business School.